Oura Targets US IPO as Smart Ring Maker’s Valuation Soars to $16 Billion

Bloomberg reports that Oura, a leading smart ring maker, is targeting a U.S. IPO as soon as next month, aiming to raise up to $3 billion with a valuation potentially surpassing $16 billion. Headquartered in San Francisco and Finland, Oura employs over 900 staff, and this listing is expected to include substantial share sales by existing investors.
This projected valuation marks a sharp rise from the $10.9 billion figure during Oura’s Series E round last September. That funding, totaling $875 million, was supported by Fidelity, ICONIQ, Whale Rock, and Atreides, alongside previous backers like Dexcom, The Chernin Group, Forerunner Ventures, Coatue, and Temasek.
As health data, AI analytics, and smart hardware converge, wearable competition is heating up. Samsung introduced the Galaxy Ring two years ago, while Whoop has grown its user base by adding hormone tracking, menopause support, and thyroid testing, reaching a $10 billion valuation in March. Oura has similarly shifted from niche biohacking tools to a broader consumer brand focused on sleep and recovery.
In May, Oura confidentially submitted its IPO paperwork. Financial projections indicate revenue of roughly $500 million in 2024, $1 billion in 2025, and nearly $2 billion by 2026.
Despite these prospects, Oura faces legal challenges ahead of its public debut. A proposed class-action lawsuit in San Francisco alleges the company exaggerated the accuracy of its sleep tracking. Plaintiffs claim Oura’s sleep stage measurements do not match medical-grade devices. Oura plans to defend itself, citing multiple studies and comparisons with polysomnography that support its accuracy claims.
Driven by rising demand for AI-powered health management, smart rings are emerging as a key growth area in wearables. Oura’s IPO will be a critical indicator of how AI health hardware commercializes.
Related article
AI firms slash costs as clients grow wary of large model expenses and lose faith in mainstream labs
As AI adoption accelerates across enterprises, soaring token costs have left many users struggling with budget constraints. To help businesses escape the "the more you use, the more expensive it gets" cycle, AI provider Writer officially released its
Apple Clarifies Gemini Rumors: Siri AI to Be Built In-House
Following the 2026 Worldwide Developers Conference (WWDC), Apple addressed media inquiries regarding rumors that its new AI infrastructure was merely a "Gemini shell." The company clarified that Apple Foundation Models (AFM) are not a rebranding of G
OpenAI Still Struggles to Control Rogue AI Activity
On Friday, OpenAI launched a dedicated page for “misalignment reports,” revealing an alarming volume of rogue behaviors documented over an extended period. The site currently lists nine incidents, the majority occurring during reinforcement learning
Related Special Topic Recommendations
Comments (0)
0/500

Bloomberg reports that Oura, a leading smart ring maker, is targeting a U.S. IPO as soon as next month, aiming to raise up to $3 billion with a valuation potentially surpassing $16 billion. Headquartered in San Francisco and Finland, Oura employs over 900 staff, and this listing is expected to include substantial share sales by existing investors.
This projected valuation marks a sharp rise from the $10.9 billion figure during Oura’s Series E round last September. That funding, totaling $875 million, was supported by Fidelity, ICONIQ, Whale Rock, and Atreides, alongside previous backers like Dexcom, The Chernin Group, Forerunner Ventures, Coatue, and Temasek.
As health data, AI analytics, and smart hardware converge, wearable competition is heating up. Samsung introduced the Galaxy Ring two years ago, while Whoop has grown its user base by adding hormone tracking, menopause support, and thyroid testing, reaching a $10 billion valuation in March. Oura has similarly shifted from niche biohacking tools to a broader consumer brand focused on sleep and recovery.
In May, Oura confidentially submitted its IPO paperwork. Financial projections indicate revenue of roughly $500 million in 2024, $1 billion in 2025, and nearly $2 billion by 2026.
Despite these prospects, Oura faces legal challenges ahead of its public debut. A proposed class-action lawsuit in San Francisco alleges the company exaggerated the accuracy of its sleep tracking. Plaintiffs claim Oura’s sleep stage measurements do not match medical-grade devices. Oura plans to defend itself, citing multiple studies and comparisons with polysomnography that support its accuracy claims.
Driven by rising demand for AI-powered health management, smart rings are emerging as a key growth area in wearables. Oura’s IPO will be a critical indicator of how AI health hardware commercializes.
AI firms slash costs as clients grow wary of large model expenses and lose faith in mainstream labs
As AI adoption accelerates across enterprises, soaring token costs have left many users struggling with budget constraints. To help businesses escape the "the more you use, the more expensive it gets" cycle, AI provider Writer officially released its
Apple Clarifies Gemini Rumors: Siri AI to Be Built In-House
Following the 2026 Worldwide Developers Conference (WWDC), Apple addressed media inquiries regarding rumors that its new AI infrastructure was merely a "Gemini shell." The company clarified that Apple Foundation Models (AFM) are not a rebranding of G
OpenAI Still Struggles to Control Rogue AI Activity
On Friday, OpenAI launched a dedicated page for “misalignment reports,” revealing an alarming volume of rogue behaviors documented over an extended period. The site currently lists nine incidents, the majority occurring during reinforcement learning





Home






